In this study, we identified SETMAR as a differentiation‐related histone methylation modifier in thyroid cancer, and we found that its mRNA was stabilized by METTL3‐mediated m6A modification in an IGF2BP3‐dependent manner. This evidence concerns the gene SETMAR and thyroid cancer.